Strongly criticized pharmaceutical company

References

PRDpp. 25, 42–43, 59, 66, 71, 106–107, 123
anonpp. 50, 77–78, 147, 149–150, 152
Systempp. 31, 37–39, 52, 129, 148, 177, 240, 246, 252, 258, 285, 292, 296–297